Jacobi Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Jacobi Capital Management’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-750	Closed	-$56K	–	1046
2021 Q3	$56K	Hold	750	–	–	0.01%	631
2021 Q2	$58K	Hold	750	–	–	0.01%	592
2021 Q1	$55K	Hold	750	–	–	0.01%	555
2020 Q4	$53K	Buy	750 +150	+25%	+$9.5K	0.01%	526
2020 Q3	$34K	Hold	600	–	–	0.01%	562
2020 Q2	$35K	Sell	600 -200	-25%	-$10.9K	0.01%	537
2020 Q1	$37K	Hold	800	–	–	0.01%	476
2019 Q4	$45K	Hold	800	–	–	0.01%	486
2019 Q3	$38K	Hold	800	–	–	0.01%	492
2019 Q2	$43K	Hold	800	–	–	0.01%	477
2019 Q1	$44K	Sell	800 -400	-33%	-$21.1K	0.01%	434
2018 Q4	$56K	Hold	1,200	–	–	0.02%	372
2018 Q3	$71K	Hold	1,200	–	–	0.02%	369
2018 Q2	$66K	Hold	1,200	–	–	0.02%	374
2018 Q1	$57K	Hold	1,200	–	–	0.02%	372
2017 Q4	$58K	Hold	1,200	–	–	0.02%	346
2017 Q3	$60K	Hold	1,200	–	–	0.02%	315
2017 Q2	$55K	Hold	1,200	–	–	0.02%	292
2017 Q1	$49K	Buy	1,200 +400	+50%	+$16.8K	0.03%	242
2016 Q4	$32K	Sell	800 -400	-33%	-$16.2K	0.02%	270
2016 Q3	$50K	Buy	1,200 +400	+50%	+$16.4K	0.02%	234
2016 Q2	$31K	Buy	+800	New	+$31.4K	0.02%	296

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

Jacobi Capital Management's PBE Position: Q4 2021 in Review

Jacobi Capital Management sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2021, closing a stake of 750 shares — an estimated $56K sold.

Jacobi Capital Management first reported a position in PBE in Q2 2016 and held it in 22 quarters. The position peaked at $71K in Q3 2018. 101 funds tracked by Wall St. Rank hold PBE as of Q4 2021.

Jacobi Capital Management reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 750 Invesco Biotechnology & Genome ETF shares in Q4 2021, an estimated $56K.
Jacobi Capital Management first reported a position in Invesco Biotechnology & Genome ETF in Q2 2016 and held it in 22 quarters.
Jacobi Capital Management's Invesco Biotechnology & Genome ETF position peaked at $71K in Q3 2018.
101 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.